Ignite Creation Date:
2025-12-24 @ 10:51 PM
Ignite Modification Date:
2026-06-21 @ 4:09 PM
Study NCT ID:
NCT05119569
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-10
First Post:
2021-10-29
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Investigate the Efficacy of Fenebrutinib in Relapsing Multiple Sclerosis (RMS)
Sponsor:
Hoffmann-La Roche
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Relapsing Multiple Sclerosis | View |
Keywords: